September 23, 2024 Medicaid Drug Rebate Program (MDRP) Summit 2024 IntegriChain is proud to be a sponsor of this year’s Medicaid Drug Rebate Program (MDRP) event, contributing thought leadership on key topics such as IRA rebates and IRA drug price negotiations and best practices around this topic. Our sessions will delve into the latest IRA Medicare Part D changes, offering insights and best practices for navigating this evolving landscape and how pharmaceutical manufacturers can prepare for new rebates. Jeff BaabPartner, Advisory Services Session: IRA Negotiation Insights, Potential Implications, and Best Practices for Preparation Date | Time: Tuesday, September 24 | 10:55AM – 11:35 AM Description: In this session Jeff Baab, Partner, Advisory Services and Kristin Hicks, Partner at Arnold and Porter, will cover topics including: Refresh on the Medicare Drug Price Negotiation Program Insights from the publication of MFPs from the first round of negotiation How may future rounds of negotiation differ? What to prepare and best practices on process Market access implications of the MFP and changing Part D dynamics For more on the topics in this presentation, please read our consulting blog post on the IRA. Register here. Jake KeenanVice President, GP Managed Services Session: Taking Action on the IRA – Operationalizing the Upcoming New Rebates of the IRA and Discarded Drug Refunds Date | Time: Tuesday, September 24 | 2:50 PM – 3:30 PM Description: In this session, Keenan will explore how pharmaceutical manufacturers can start preparing for the various new rebates that are part of the Inflation Reduction Act along with the refunds due from the Discarded Drug units. This includes discussing the operational considerations in receiving, validating, and paying the new invoices. In addition Keenan will review what modifications to rebate systems and processes will be needed to be efficient and accurate in the new IRA environment. Register here.
